Fortis BioPharma, LLC – Trademark Portfolio
Entity Type: 16
Fortis BioPharma, LLC owns a portfolio of 18 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as HY2C, BUZZKILL, and NATURMETIC. Of these, 3 are registered. The portfolio spans 4 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 3 (Cosmetics & Cleaning). Headquartered in Columbia, SC.
Suite 1
911 Lady Street
Columbia, SC 29201
Showing of trademarks Trademarks
Trademark Classifications
Fortis BioPharma, LLC's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Fortis BioPharma, LLC have?
Fortis BioPharma, LLC has 18 U.S. trademarks filed with the USPTO. Of these, 3 registered, 13 abandoned, 2 cancelled.
What trademark classes does Fortis BioPharma, LLC file in?
Fortis BioPharma, LLC files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 10 (Medical Apparatus), Class 44 (Medical Services). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Fortis BioPharma, LLC's most well-known trademarks?
Fortis BioPharma, LLC's registered trademark portfolio includes well-known marks such as HY2C, BUZZKILL, and NATURMETIC. These are among 3 currently registered trademarks in the portfolio.
What is Fortis BioPharma, LLC's trademark registration success rate?
Fortis BioPharma, LLC has a 17% trademark registration rate, with 3 out of 18 resolved applications resulting in successful registration. Currently, 0 applications are pending review.